ALA arovella therapeutics limited

MST Financial Initiation Report - CAR-iNKT, Next Gen Cancer Killer

  1. 447 Posts.
    lightbulb Created with Sketch. 116
    MST Financial has put out an initial report, with a valuation of $0.34

    A really well written report spelling out the difference between CAR-T and its limitations and iNKT and what we think will be the future of Blood & Solid tumour treatments

    https://hotcopper.com.au/data/attachments/6657/6657640-e5d941e56a2c9a8f6d794e106b512590.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.0¢
Change
-0.004(4.76%)
Mkt cap ! $95.68M
Open High Low Value Volume
8.3¢ 8.3¢ 8.0¢ $22.44K 274.1K

Buyers (Bids)

No. Vol. Price($)
5 197985 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 43665 1
View Market Depth
Last trade - 16.10pm 15/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.